Skip to Content

5 Results Found

  • Article
  • Open Access
33 Citations
9,106 Views
14 Pages

Psoralen Inactivation of Viruses: A Process for the Safe Manipulation of Viral Antigen and Nucleic Acid

  • Katherine Schneider,
  • Loni Wronka-Edwards,
  • Melissa Leggett-Embrey,
  • Eric Walker and ,
  • Peifang Sun,
  • Brian Ondov,
  • Travis H. Wyman,
  • MJ Rosovitz,
  • Sherry S. Bohn and
  • Tadeusz Kochel
  • + 6 authors+ 1 author

12 November 2015

High consequence human pathogenic viruses must be handled at biosafety level 2, 3 or 4 and must be rendered non-infectious before they can be utilized for molecular or immunological applications at lower biosafety levels. Here we evaluate psoralen-in...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
21 Citations
7,721 Views
10 Pages

13 March 2018

Complete inactivation of infectious Ebola virus (EBOV) is required before a sample may be removed from a Biosafety Level 4 laboratory. The United States Federal Select Agent Program regulations require that procedures used to demonstrate chemical ina...

(This article belongs to the Collection Advances in Ebolavirus, Marburgvirus, and Cuevavirus Research)
  • Protocol
  • Open Access
1 Citations
2,998 Views
12 Pages

Comprehensive Assessment of Inactivation Methods for Madariaga Virus

  • RuthMabel Boytz,
  • Kadiatou Keita,
  • Joanna B Pawlak and
  • Maudry Laurent-Rolle

30 January 2024

The Eastern Equine Encephalitis Virus (EEEV) is an emerging public health threat, with the number of reported cases in the US increasing in recent years. EEEV is a BSL3 pathogen, and the North American strain is a US Federal Select Agent (SA). These...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
15 Citations
9,199 Views
22 Pages

Art of the Kill: Designing and Testing Viral Inactivation Procedures for Highly Pathogenic Negative Sense RNA Viruses

  • Judith Olejnik,
  • Adam J. Hume,
  • Stephen J. Ross,
  • Whitney A. Scoon and ,
  • Scott Seitz,
  • Mitchell R. White,
  • Ben Slutzky,
  • Nadezhda E. Yun and
  • Elke Mühlberger
  • + 4 authors+ 0 author

The study of highly pathogenic viruses handled under BSL-4 conditions and classified as Select Agents frequently involves the transfer of inactivated materials to lower containment levels for downstream analyses. Adhering to Select Agent and BSL-4 sa...

(This article belongs to the Special Issue Editorial Board Members’ Collection Series: Molecular Epidemiology, Diagnostics and Management of Viral Pathogens)
  • Article
  • Open Access
4 Citations
2,759 Views
21 Pages

Harnessing Hazara Virus as a Surrogate for Crimean–Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level

  • Judith Olejnik,
  • Kristina Meier,
  • Jarod N. Herrera,
  • Daniel J. DeStasio and ,
  • Dylan J. Deeney,
  • Elizabeth Y. Flores,
  • Mitchell R. White,
  • Adam J. Hume and
  • Elke Mühlberger
  • + 4 authors+ 0 author

Research on highly pathogenic biosafety level 4 (BSL-4) viruses that are classified as Select Agents involves transferring inactivated materials to lower containment levels for further analysis. Compliance with Select Agent and BSL-4 safety regulatio...

(This article belongs to the Special Issue Editorial Board Members’ Collection Series: Molecular Epidemiology, Diagnostics and Management of Viral Pathogens)